Fundraising FoxWhat If Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Affect Therapeutics operates an app-based digital treatment provider offering care for substance use disorders (alcohol, cannabis, opioid) and mental health conditions like depression and anxiety, using methods such as contingency management, CBT, medication-assisted treatment, and peer support.
Digital HealthHealthtechMental HealthNew York, US
Jeff DeFlavio(Co-founder)inKristin Muhlner(Executive Officer, Director)in
BoardKevin Ryan(Director)inJeff Rinehart(Director)in
PartnerStephen Hays· solo GP
Co-investorsArtis VenturesCity LightAlleyCorpGaingelsKapor CapitalLifeArc Ventures+3 more
__Twitter.png)
HealthtechSaratoga Springs, US
Daniel T. Pickett III(Executive Officer, Director)Timothy Koehler(Executive Officer)Greg Stephen(Executive Officer)
BoardHolly Benson(Director)Mary Langowski(Director)Peter Dorsman(Director)
PartnerStephen Hays· solo GP
Co-investorsClaritas CapitalOlive Tree VenturesPivotal Life SciencesTakeda VenturesVista Equity Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.